ITGAX and obesity disorder: Previous studies have shown that ablation of CD11c+ cells [25] or reduction of their cytokine production [28] mitigates insulin resistance in obesity, suggesting that at least part of the metabolic impairment we observed in SL-HFD mice is attributed to the large increase in M1 macrophage recruitment and subsequent cytokine production.